FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20230811E00346
1. Date of relevant event: 08/08/2023
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 06990
4. Name of listed corporation: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 
5. Class of shares: H Shares 
6. Number of issued shares in class: 64,057,171
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) LIU
(Other names) Gexin
10. Name of director (Chinese): 刘革新 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1711Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box)
 
2201Interest of corporation controlled by you
 
2201Interest of corporation controlled by you
 		 12,782,700         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position12,782,70021.06
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position12,782,70019.96
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position12,782,700
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
四川科伦药业股份有限公司中国成都市新都卫星城工业开发区南二路 （中国）刘革新25.70N
Long position12,782,700
科伦国际发展有限公司香港中环康乐广场一号怡和大厦402室（香港）四川科伦药业股份有限公司100.00Y
Long position3,782,700
成都科伦晶川科技有限公司中国成都市温江区成都海峡两岸科技产业开发园新华大道666号（中国）四川科伦药业股份有限公司100.00N
Long position9,000,000
成都科伦汇才企业管理中心(有限合伙)中国成都市温江区成都海峡两岸科技产业开发园新华大道666号（中国）成都科伦晶川科技有限公司(作为普通合伙人)100.00Y
Long position2,250,000
成都科伦汇德企业管理中心(有限合伙)中国成都市温江区成都海峡两岸科技产业开发园新华大道666号（中国）成都科伦晶川科技有限公司(作为普通合伙人)100.00Y
Long position2,250,000
成都科伦汇能企业管理中心(有限合伙)中国成都市温江区成都海峡两岸科技产业开发园新华大道666号（中国）成都科伦晶川科技有限公司(作为普通合伙人)100.00Y
Long position2,250,000
成都科伦汇智企业管理中心(有限合伙)中国成都市温江区成都海峡两岸科技产业开发园新华大道666号（中国）成都科伦晶川科技有限公司(作为普通合伙人)100.00Y
Long position2,250,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: 有关方格24而言，上市法团于 2023 年 8 月 3 日获悉数行使超额配股权，并于 2023年8 月 8 日发行了 3,366,900 股 H 股，这对刘革新先生在上市法团中的权益造成摊薄影响, 使其权益百分率数字减少。 请参阅上市法团2023年8月3日的公告。有关方格30而言，(1) 刘革新先生持有科伦药业约25.70%股权，有能力对科伦药业拥有控制权。故刘革新先生被视为于科伦药业所持有的股份中拥有权益。(2) 科伦晶川为科伦药业的全资子公司。(3) 根据科伦晶川(作为普通合伙人)分别与科伦汇才、科伦汇德、科伦汇能及科伦汇智的有限合伙人签订的合伙协议，科伦晶川(作为普通合伙人)可分别行使科伦汇才、科伦汇德、科伦汇能及科伦汇智持有股份所附带的表决权。故科伦晶川被视为于科伦汇才、科伦汇德、科伦汇能及科伦汇智所持有的股份中拥有权益。请参阅上市法团2023年6月29日的招股章程。
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 11/08/2023
(dd/mm/yyyy)